English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Comparison of Desflurane Anesthesia Versus TIVA-TCI in Patients Undergoing Ophthalmic Ambulatory Surgery

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusCompleted
Sponsors
Xiaoliang Gan

Keywords

Abstract

This is a single-center, randomized, prospective research which aims to investigate the advantages and disadvantages between desflurane balanced anesthesia and TIVA-TCI with propofol in ophthalmic ambulatory surgery, so that to evaluate a better anesthesia method in ophthalmic surgery through a large sample clinical study.

Description

Desflurane balanced anesthesia and TIVA-TCI(Total IntraVenous Anesthesia-Target Controlled Infusion) are commonly used in ophthalmic ambulatory surgery, however, there is no clear evidence to discriminate the advantages and disadvantages between them. This study is designed to evaluate a better anesthetic method in ophthalmic surgery through a clinical study. This is a single center, randomized, prospective study. 200 patients with American Society of Anesthesiologists'(ASA) physical status 1 to 2, aged 18 to 60, scheduled for elective strabismus ambulatory and in whom a LMA is indicated for anesthesia are recruited. Enrolled patients are randomly assigned into 2 groups: group TIVA (TIVA-TCI with propofol) and group Des (Desflurane).In group TIVA, anesthesia is maintained with propofol and remifentanil. Propofol is continuously administered via a target-controlled infusion (TCI) pump intraoperatively. In group Des, anesthesia is maintained with desflurane.All patients received anaesthesia depth monitoring with bispectral index (BIS). The dose of anesthetic is adjusted to maintained the BIS value within 40 to 60. At the end of the surgery, inhalant anesthetic or infused propofol and remifentanil are discontinued. LMA is removed when patient regains consciousness with spontaneous respiration. Patients are then transferred to the post anesthetic care unit (PACU) for postoperative follow-up. The primary outcome is awake time, the secondary outcomes include discharge time, the stay time in PACU, time of off-bed, Riker sedation agitation score (SAS), time of PADSS>9, NRS score when leaving PACU, incidence of various complications (postoperative nausea and vomiting (PONV), emergence agitation, etc), as well as anesthesia cost. All patients are followed up by calling in one day after the surgery.

Dates

Last Verified: 12/31/2017
First Submitted: 09/27/2016
Estimated Enrollment Submitted: 09/29/2016
First Posted: 10/03/2016
Last Update Submitted: 01/20/2018
Last Update Posted: 01/22/2018
Actual Study Start Date: 09/30/2016
Estimated Primary Completion Date: 11/30/2017
Estimated Study Completion Date: 12/31/2017

Condition or disease

Ophthalmic
Surgery
Anesthesia

Intervention/treatment

Drug: Group Des

Procedure: Group TIVA

Procedure: Group Des

Drug: Group TIVA

Drug: Group TIVA

Phase

-

Arm Groups

ArmIntervention/treatment
Experimental: Group TIVA
method of anesthesia is total intravenous anesthesia(TIVA) and maintenance with propofol Cp 2—4 μg/ml and remifentanil 2—4 ng/ml in target controlled infusion(TCI) during the procedure
Procedure: Group TIVA
method of anesthesia in group TIVA is total intravenous anesthesia(TIVA) during the procedure
Experimental: Group Des
method of anesthesia is inhalation anesthesia and maintenance with desflurane ranged from 0.5~1.5 MAC during the procedure
Drug: Group Des
method of anesthesia maintenance with desflurane ranged from 0.5~1.5 MAC during the procedure

Eligibility Criteria

Ages Eligible for Study 18 Years To 18 Years
Sexes Eligible for StudyAll
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

- 18-60 years patients undergoing selective ophthalmic ambulatory surgery;

- ASA I and II

- duration of anesthesia at least 30min

- without apparent organ comorbidities

- sign the informed consent form

Exclusion Criteria:

- equal or greater than ASA III

- has a history of dementia,psychiatric disorders or central nervous system diseases

- taking sedatives, antidepressant or glucocorticoid

- without family members

- has cardiac, respiratory,liver,kidney comorbidities

- uncontrolled hypertension(>180/100mmHg)

- laryngeal mask fail to insert, and change to tracheal intubation

Outcome

Primary Outcome Measures

1. Awake time [From the ending time of anesthesia until the recovery time of patient's consciousness, assessed up to half an hour postoperatively.]

"Anesthesia ends" means stop infusing or inhaling any anaesthetic.

Secondary Outcome Measures

1. Discharge time [From the ending time of anesthesia until the time of extubation, assessed up to half an hour postoperatively.]

The standards of extubation are tidal volume(VT) 6~8 ml/kg,respiratory rate(RR) 10~12 times per minute,end-tidal carbon dioxide (ETCO2) 35~45 mmHg.

2. Stay time in the postoperative care unit [Measuring the stay time in postoperative care unit, assessed up to one hour postoperatively.]

3. Quality of recovery in 1 day postoperatively [Start scaling when 1 day(24 hour) postoperatively.]

It will use telephone follow-up for the patients enrolled.

4. Incidences in postoperative nausea and vomiting(PONV) [Start scaling in 1 day(24 hour) postoperatively.]

5. Incidences in postoperative agitation [Start scaling in 1 day(24 hour) postoperatively.]

6. Anesthesia cost [During the procedure of anesthesia.]

7. Postoperative VAS pain score [Start scaling in half an hour postoperatively when patient's consciousness returns.]

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge